March 26 (Reuters) - BOD Australia Ltd (BDA) : PHASE I CLINICAL TRIAL DEMONSTRATES BOD'S PATENTED CBD WAFER SUPERIORITY Source text http://bit.ly/2Tvwthy (([email protected];))
ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024